The TERIL brand, founded in 1998 (Israel), from 2 sister brands and 4958 competing brands. The TERIL brand is owned by Taro Pharm, a company listed in New York. The ISIN, the company's International Securities Identification Number, is IL0010827181. TERIL belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Taro Pharm
(TERIL)
over 5 years*
USD 16.76